Linli Tian

2.4k total citations
50 papers, 1.7k citations indexed

About

Linli Tian is a scholar working on Molecular Biology, Cancer Research and Otorhinolaryngology. According to data from OpenAlex, Linli Tian has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 25 papers in Cancer Research and 9 papers in Otorhinolaryngology. Recurrent topics in Linli Tian's work include Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (14 papers) and Circular RNAs in diseases (12 papers). Linli Tian is often cited by papers focused on Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (14 papers) and Circular RNAs in diseases (12 papers). Linli Tian collaborates with scholars based in China, United States and Russia. Linli Tian's co-authors include Yanan Sun, Jingting Wang, Xin Wang, Lingmei Qu, Qiuying Li, Jianguang Lu, Rui Zhao, Yushan Li, Like Yang and Haoyang Yu and has published in prestigious journals such as PLoS ONE, Oncogene and Frontiers in Immunology.

In The Last Decade

Linli Tian

50 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linli Tian China 20 1.4k 1.3k 112 82 80 50 1.7k
Hiroaki Nagata Japan 16 1.2k 0.8× 1.1k 0.9× 207 1.8× 94 1.1× 111 1.4× 35 1.6k
Kai Hu China 17 379 0.3× 244 0.2× 196 1.8× 82 1.0× 197 2.5× 53 794
Tingting Hu China 17 422 0.3× 170 0.1× 205 1.8× 91 1.1× 113 1.4× 73 884
Chengwei Zhou China 19 1.2k 0.8× 1.1k 0.9× 89 0.8× 82 1.0× 103 1.3× 59 1.5k
Francesca Pezzuto Italy 11 363 0.3× 266 0.2× 108 1.0× 107 1.3× 75 0.9× 16 672
Kazuya Kawahara Japan 10 891 0.6× 843 0.7× 60 0.5× 60 0.7× 64 0.8× 27 1.2k
Shuting Han Singapore 11 258 0.2× 179 0.1× 157 1.4× 29 0.4× 57 0.7× 23 472
Alison Marker United Kingdom 14 287 0.2× 200 0.2× 108 1.0× 24 0.3× 38 0.5× 31 774
Stefan K. Grebe United States 10 551 0.4× 521 0.4× 60 0.5× 46 0.6× 50 0.6× 23 835
Feng Xiao China 12 255 0.2× 139 0.1× 81 0.7× 95 1.2× 45 0.6× 43 535

Countries citing papers authored by Linli Tian

Since Specialization
Citations

This map shows the geographic impact of Linli Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linli Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linli Tian more than expected).

Fields of papers citing papers by Linli Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linli Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linli Tian. The network helps show where Linli Tian may publish in the future.

Co-authorship network of co-authors of Linli Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Linli Tian. A scholar is included among the top collaborators of Linli Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linli Tian. Linli Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Licheng, et al.. (2024). ANXA3-Rich Exosomes Derived from Tumor-Associated Macrophages Regulate Ferroptosis and Lymphatic Metastasis of Laryngeal Squamous Cell Carcinoma. Cancer Immunology Research. 12(5). 614–630. 23 indexed citations
2.
Liu, Xinyu, Wenjing Li, Licheng Xu, et al.. (2023). Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo. The International Journal of Biochemistry & Cell Biology. 158. 106398–106398. 9 indexed citations
3.
Xu, Licheng, Jing Cao, Pengyan Liu, et al.. (2023). DACH1 regulates macrophage activation and tumour progression in hypopharyngeal squamous cell carcinoma. Immunology. 170(2). 253–269. 3 indexed citations
4.
Xu, Licheng, et al.. (2023). Targeting reactive oxygen species and fat acid oxidation for the modulation of tumor-associated macrophages: a narrative review. Frontiers in Immunology. 14. 1224443–1224443. 15 indexed citations
5.
Tian, Linli, et al.. (2022). LncRNA TP73‐AS1 promotes nasopharyngeal carcinoma progression through targeting miR-342-3p and M2 polarization via exosomes. Cancer Cell International. 22(1). 16–16. 23 indexed citations
6.
Li, Yushan, Bingrui Yan, Xin Wang, et al.. (2021). ALKBH5‐mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9. Journal of Cellular and Molecular Medicine. 26(2). 385–398. 30 indexed citations
7.
Wang, Xin, Tianyi Wu, Peng Wang, et al.. (2020). Circular RNA 103862 Promotes Proliferation and Invasion of Laryngeal Squamous Cell Carcinoma Cells Through the miR-493-5p/GOLM1 Axis. Frontiers in Oncology. 10. 1064–1064. 17 indexed citations
8.
Zhao, Rui, Linli Tian, Bo Zhao, et al.. (2020). FADS1 promotes the progression of laryngeal squamous cell carcinoma through activating AKT/mTOR signaling. Cell Death and Disease. 11(4). 272–272. 38 indexed citations
9.
Yang, Like, et al.. (2020). LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2). Cancer Cell International. 20(1). 138–138. 20 indexed citations
10.
Wu, Tianyi, Bingrui Yan, Xuan Kan, et al.. (2020). A Novel LncRNA, AC091729.7 Promotes Sinonasal Squamous Cell Carcinomas Proliferation and Invasion Through Binding SRSF2. Frontiers in Oncology. 9. 1575–1575. 14 indexed citations
11.
Zhang, Jiarui, Rui Zhao, Jing Cao, et al.. (2020). Magnesium Isoglycyrrhizinate Induces an Inhibitory Effect on Progression and Epithelial–Mesenchymal Transition of Laryngeal Cancer via the NF-κB/Twist Signaling. Drug Design Development and Therapy. Volume 14. 5633–5644. 6 indexed citations
12.
Tian, Linli, Cunling Yan, Huiying Fang, et al.. (2019). A cross-sectional survey on patient safety culture in secondary hospitals of Northeast China. PLoS ONE. 14(3). e0213055–e0213055. 32 indexed citations
13.
Wang, Peng, Jin Meng, Like Yang, et al.. (2018). A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC). Bioscience Reports. 38(6). 22 indexed citations
14.
15.
Tian, Linli, et al.. (2017). Effect of the patient-to-patient communication model on dysphagia caused by total laryngectomy. The Journal of Laryngology & Otology. 131(3). 253–258. 5 indexed citations
16.
17.
Dong, Haiyan, Linli Tian, Rui Li, et al.. (2015). IFNg-induced Irgm1 promotes tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagy. Oncogene. 34(42). 5363–5371. 24 indexed citations
18.
Tian, Linli, Minghua Li, Yan Guo, et al.. (2014). MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. Tumor Biology. 35(6). 5953–5963. 92 indexed citations
19.
Sun, Qingfeng, Tianyi Wu, Jianguang Lu, et al.. (2013). Upregulation of ATF-3 is correlated with prognosis and proliferation of laryngeal cancer by regulating Cyclin D1 expression.. PubMed Central. 13 indexed citations
20.
Zhao, Zhigang, Jie Ge, Yanan Sun, et al.. (2012). Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis. Oral Oncology. 48(9). 761–767. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroaki Nagata Breakdown of academic impact, for papers by Kai Hu Breakdown of academic impact, for papers by Tingting Hu Breakdown of academic impact, for papers by Chengwei Zhou Breakdown of academic impact, for papers by Francesca Pezzuto Breakdown of academic impact, for papers by Kazuya Kawahara Breakdown of academic impact, for papers by Shuting Han Breakdown of academic impact, for papers by Alison Marker Breakdown of academic impact, for papers by Stefan K. Grebe Breakdown of academic impact, for papers by Feng Xiao
Rankless by CCL
2026